Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
University of Pennsylvania, Philadelphia, Pennsylvania.
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-058876.
We sought to evaluate the use of behavioral economics approaches to promote the carrying of epinephrine auto-injectors (EAIs) among adolescents with food allergies. We hypothesized that adolescents who receive frequent text message nudges (Intervention 1) or frequent text message nudges plus modest financial incentives (Intervention 2) would be more likely to carry their epinephrine than members of the usual care control group.
We recruited 131 adolescents ages 15 to 19 with a food allergy and a current prescription for epinephrine to participate in a cohort multiple randomized controlled trial. Participants were randomly assigned to participate in Intervention 1, Intervention 2, or to receive usual care. The primary outcome was consistency of epinephrine-carrying, measured as the proportion of checkpoints at which a participant could successfully demonstrate they were carrying their EAI, with photo-documentation of the device.
During Intervention 1, participants who received the intervention carried their EAI 28% of the time versus 38% for control group participants (P = .06). During Intervention 2, participations who received the intervention carried their EAI 45% of the time versus 23% for control group participants (P = .002).
Text message nudges alone were unsuccessful at promoting EAI-carrying but text message nudges combined with modest financial incentives almost doubled EAI-carriage rates among those who received the intervention compared with the control group. However, even with the intervention, adolescents with food allergies carried their EAI <50% of the time. Alternative strategies for making EAIs accessible to adolescents at all times should be implemented.
我们旨在评估行为经济学方法在促进青少年携带肾上腺素自动注射器(EAI)方面的应用。我们假设,与常规护理对照组相比,经常收到短信提示(干预 1)或经常收到短信提示加适度经济激励(干预 2)的青少年更有可能携带他们的肾上腺素。
我们招募了 131 名年龄在 15 至 19 岁之间、有食物过敏和目前有肾上腺素处方的青少年参与队列多项随机对照试验。参与者被随机分配参与干预 1、干预 2 或接受常规护理。主要结局是携带肾上腺素的一致性,以参与者在能够成功证明他们携带 EAI 的检查点的比例来衡量,同时用设备的照片记录来证明。
在干预 1 期间,接受干预的参与者携带 EAI 的比例为 28%,而对照组参与者为 38%(P =.06)。在干预 2 期间,接受干预的参与者携带 EAI 的比例为 45%,而对照组参与者为 23%(P =.002)。
单独的短信提示未能促进 EAI 携带,但短信提示与适度经济激励相结合,使接受干预的参与者的 EAI 携带率几乎增加了一倍,而对照组参与者为 23%。然而,即使有干预,食物过敏的青少年携带 EAI 的时间也不到 50%。应该实施其他策略,以便在任何时候都能让青少年获得 EAI。